NutriSystem (NASDAQ: NTRI) and Cannabis Sativa (OTCMKTS:CBDS) are both small-cap non-cyclical consumer goods services companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.
This table compares NutriSystem and Cannabis Sativa’s net margins, return on equity and return on assets.
Valuation and Earnings
This table compares NutriSystem and Cannabis Sativa’s revenue, earnings per share (EPS) and valuation.
NutriSystem has higher revenue and earnings than Cannabis Sativa. Cannabis Sativa is trading at a lower price-to-earnings ratio than NutriSystem, indicating that it is currently the more affordable of the two stocks.
NutriSystem has a beta of 1.01, indicating that its stock price is 1% more volatile than the SP 500. Comparatively, Cannabis Sativa has a beta of -7.51, indicating that its stock price is 851% less volatile than the